这是描述信息

R &D Platform

Check category

Product search

搜索
Search

R&D Results

  • Categories:R & D results
  • Author:
  • Origin:
  • Time of issue:2020-04-15 21:54
  • Views:

(Summary description) Weite Pharmaceutical has always regarded technological innovation as an important strategy for the development of enterprises, with greater investment in innovative drug research, and continued to increase the Company's independent innovative ability.

R&D Results

(Summary description) Weite Pharmaceutical has always regarded technological innovation as an important strategy for the development of enterprises, with greater investment in innovative drug research, and continued to increase the Company's independent innovative ability.

  • Categories:R & D results
  • Author:
  • Origin:
  • Time of issue:2020-04-15 21:54
  • Views:
Information

  Weite Pharmaceutical has always regarded technological innovation as an important strategy for the development of enterprises, with greater investment in innovative drug research, and continued to increase the Company's independent innovative ability.

 

生产批件

  No.

Variety

category Spec. Product with code number approved by SFDA

1

Irbesartan Active pharmaceutical ingredients (APIs)

--

H20000535

2

Telmisartan Active pharmaceutical ingredients (APIs)

--

H20041740

3

Telmisartan tablets Tablet

40mg

H20041741

4

Nizatidine dispersible tablets Tablet

0.15g

H20090065

5

Azithromycin dispersible tablets Tablet

0.125g

H20083658

6

Wuziyanzong tablets Tablet Each tablet weighs 0.3 g

Z20064394

7

Metoprolol tartrate tablets Tablet

25 mg

H20123193

8

Tinidazole vaginal effervescent tablets Tablets (effervescent)

0.2 g

H20063293

9

Tablet for Traumatic Injuries Tablets (thin film coated tablets) Each tablet weighs 0.3 g

Z20093418

10

Nuangongyunzi Capsule Capsule 0.32g per capsule

Z20090224

11

Omeprazole enteric-coated capsules Capsule

20mg

H20143185

12

Nimesulide capsules Capsule

0.1g

H20083692

13

Valacyclovir hydrochloride capsules Capsule

0.15g

H20103510

14

Gengnianling Capsule Capsule 0.28 g per capsule

Z20064428

15

Shenqi Ejiao granules Granules 5 g per bag

Z20090740

16

Hydrotalcite Granule Granules

2g:0.5g

H20093294

17

Bismuth Potassium Citrate Granules Granules 1.2 g per bag containing 110 mg of bismuth

H20063864

18

Paracetamol Chewable Tablets Tablet 160mg per tablet

H20083658

 

获得专利

No. Patent name Application number or patent number

1

Telmisartan and amlodipine compound preparation and preparation method

201010108196.8

2

Packaging design patent

201030164577.9

3

Design patent for packaging box (Shenqi Ejiao granules) 1

201630428696.8

4

Design patent for packaging box (Shenqi Ejiao granules) 2

201630428699.1

 

 

Scan the QR code to read on your phone

Previous: None
Next: None
Previous: None
Next: None

Human resource

——

Talent Management

 

 

 

 

Contact Information

——
86-731-84731399

Manufacturing base address: No.9 Kangping Road, Economic Development Zone, Liuyang

Office address in Changsha: Floor 8, business building, Mawangdui Science and Technology Park, No. 948, Yuanda First Road, Changsha

 

WeChat

WeChat